Table of Contents

company-logo

Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non–alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19 in Canada and Australia. The company's lead candidate is NP-120, an N-methyl-d-aspartate (NMDA) receptor glutamate receptor antagonist, which targets NMDA-type subunit 2B (Glu2NB), as well as exhibits agonist activity for the Sigma-1 receptor, a chaperone protein up-regulated during endoplasmic reticulum stress. It is also developing AP-188, a psychedelic compound that is part of the tryptamine family for the treatment of ischemic stroke in humans. Algernon Pharmaceuticals Inc. has an agreement with Charles River Laboratories for preclinical studies of AP-188 for the company's stroke clinical research program. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Algernon Pharmaceuticals Dividend Announcement

• Algernon Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Algernon Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Algernon Pharmaceuticals Dividend History

Algernon Pharmaceuticals Dividend Yield

Algernon Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Algernon Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Algernon Pharmaceuticals Financial Ratios

P/E ratio-0.70
PEG ratio-0.02
P/B ratio0.93
ROE-213.50%
Payout ratio0.00%
Current ratio0.36
Quick ratio0.36
Cash Ratio0.32

Algernon Pharmaceuticals Dividend FAQ

Does Algernon Pharmaceuticals stock pay dividends?
Algernon Pharmaceuticals does not currently pay dividends to its shareholders.
Has Algernon Pharmaceuticals ever paid a dividend?
No, Algernon Pharmaceuticals has no a history of paying dividends to its shareholders. Algernon Pharmaceuticals is not known for its dividend payments.
Why doesn't Algernon Pharmaceuticals pay dividends?
There are several potential reasons why Algernon Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Algernon Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Algernon Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Algernon Pharmaceuticals a dividend aristocrat?
Algernon Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Algernon Pharmaceuticals a dividend king?
Algernon Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Algernon Pharmaceuticals a dividend stock?
No, Algernon Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Algernon Pharmaceuticals stocks?
To buy Algernon Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Algernon Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.